|premium|

PLTR News: Palantir Technologies tumbles as OPEX week pins markets

  • NYSE:PLTR dropped by 3.96% on Wednesday amidst a broader growth sector sell off.
  • The Department of Defense Jedi contract is officially up for grabs.
  • Palantir holds support at the $21.00 level, but a break lower could be trouble.

NYSE:PLTR is officially in trouble as the broader growth sector sell off on Wednesday pushed the stock down towards another support area. Shares of Palantir fell by 3.96% on Wednesday, and closed the trading session at $21.56. It has been a bloody week for Palantir so far and it just happens to coincide with OPEX, or the week where options contracts expire for the month of July. OPEX week has historically caused the markets to remain stagnant as market makers attempt to hold prices to maximize profits from writing options contracts. 


Stay up to speed with hot stocks' news!


An interesting piece of news hit the markets last week as the Department of Defense officially called off its Jedi Cloud contract with Microsoft (NASDAQ:MSFT) that is valued at an estimated $10 billion. Microsoft won the contract with its Azure cloud services, beating out Amazon (NASDAQ:AMZN) and its AWS platform in the end. Many have pointed at Palantir as a potential threat for the contract given its ongoing relationship with the U.S. government. Palantir has recently secured deals with the FAA and the U.S. Army among numerous other government agencies, and adding the Department of Defense wouldn’t be out of the realm of possibilities.

PLTR stock forecast

Palantir traders are watching the $21.00 price level as the final level of support for the stock before it could plummet below the $20.00 price barrier. Thus far, Palantir has broken down through all previous levels of support and given the current market sentiment towards growth stocks, Palantir may need to fall further before reversing this downward trend into bearish territory. 

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

More from Stocks Reporter
Share:

Editor's Picks

EUR/USD struggles to hold above 1.1800 ahead of US data

EUR/USD finds it difficult to gather recovery momentum and retreats below 1.1800 in the second half of the day on Thursday. The US Dollar (USD) stays resilient against its peers after the hawkish surprise in FOMC Minutes, weighing on the pair ahead of the next batch of US data.

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold retreats from daily highs, trades below $5,000

Gold finds it difficult to stabilize above the $5,000 psychological mark on Thursday and trades slightly below this level in the early American session. Escalating geopolitical tensions in the Middle East help XAU/USD hold its ground, while the broad-based USD strength caps the pair's upside.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.